Iovance Biotherapeutics Inc at Piper Sandler Healthcare Conference (Virtual)- Pre-recorded Fireside Chat Transcript
Perfect. Well, thanks so much to everybody who's tuning in here. I'm Joe Catanzaro. I'm one of Piper's biotech analyst.
It's my pleasure to welcome Iovance and their President and CEO, Maria Fardis. Maria, thanks so much for making the time here.
Questions & Answers
I guess if we could just jump straight into it and, obviously, maybe start with non-small cell lung cancer. So we recently got some details around the Phase II IOV-LUN-202 trial design. I guess, first, walk us through that trial design and, specifically, the thought process that went into the type of patients that you want to enroll into those cohorts given sort of the emphasis you had put into the thought process around designing this trial.
Yes, absolutely
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
